Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas
NCT02364089Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Apr 2015
- Primary completion
- Mar 2022
- Countries
- 3
01
Overview
Randomised, open-label trial in Adrenal incidentaloma (AI) and hypertension (HTN) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Blood pressure value and Standardized anti-hypertensive drug regimen (SAHR) step at 13 months. Started Apr 2015; status: completed.
02
Conditions
Adrenal incidentaloma (AI)hypertension (HTN)
Beyond the preview
Go deeper on NCT02364089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364089.